RESUMO
BACKGROUND: Infusion tests, which measure resistance to outflow (Rout), are used in selecting patients suspected for idiopathic normal pressure hydrocephalus (iNPH) for shunt surgery. Infusion tests can be performed through an external ventricular drain (EVD). A 24-hour time gap from EVD insertion to an infusion test is a routine practice at our department due to concerns that the surgical procedure might influence the test results in the immediate postoperative period. The objective of the study was to investigate if timing of an intraventricular infusion test influences the results of the test in patients suspected for iNPH. METHODS: Ten patients scheduled for an intraventricular infusion test were included. Measurements of baseline intracranial pressure (ICP) and plateau ICP were obtained during constant rate intraventricular infusion test performed at two time points (1 and 24 h after EVD insertion) and Rout was calculated from these measures and compared within patients. RESULTS: Eight patients completed both infusion tests. In one of the 18 infusion tests performed, it was not possible to define an ICP plateau and this infusion test was excluded, leaving 7 paired infusion tests. Median Rout was 12.9 mmHg/ml/min (range 7.0-22.0) 1 h after EVD insertion and 11.3 mmHg/ml/min (range 7.8-18.1) after 24 h. Overall, there were no statistically significant differences in Rout (P = 0.83), baseline ICP (P = 0.70), or plateau ICP (P = 0.81) between the recordings performed 1 h and 24 h after EVD insertion. For two of the seven patients with paired infusion tests, there was poor agreement between Rout values at 1 and 24 h. CONCLUSION: Overall, Rout estimates do not change significantly between 1 and 24 h after EVD insertion. We therefore propose that infusion tests can be performed shortly after surgery to reduce the period of indwelling EVD and duration of hospitalization.
Assuntos
Hidrocefalia de Pressão Normal/diagnóstico , Pressão Intracraniana/fisiologia , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Hidrocefalia de Pressão Normal/fisiopatologia , Infusões Intraventriculares , Masculino , Pessoa de Meia-IdadeRESUMO
BACKGROUND: Prophylactic vitamin A supplementation (VAS) reduces mortality and may reduce morbidity associated with diarrhea in children >6 months of age. Rotavirus is the most common cause of acute dehydrating diarrhea among children worldwide. METHODS: In a randomized placebo-controlled study of 50,000 IU of vitamin A versus placebo given with bacille Calmette-Guérin vaccine at birth, 287 infants were followed up with weekly interviews and stool sample obtainment to test the hypothesis that VAS reduced the risk of rotavirus infection. RESULTS: VAS was associated with increased risk of rotavirus infection and diarrhea (incidence rate ratio [IRR] of infection, 1.72 [95% confidence interval (CI), 1.04-2.85]; IRR of diarrhea, 3.74 [95% CI, 1.40-9.98]) among children <6 months of age. There was no effect in older children. VAS had a beneficial effect on nonrotavirus diarrhea in boys <6 months of age (IRR, 0.51; 95% CI, 0.27-0.95) and a detrimental effect in girls >6 months of age (IRR, 1.84; 95% CI, 0.96-3.55). CONCLUSION: VAS at birth did not reduce rotavirus morbidity. The effect of VAS on nonrotavirus diarrhea may differ by sex, being more beneficial in boys. Clinical trials registration. NCT00168597 .
Assuntos
Vacina BCG/administração & dosagem , Diarreia/prevenção & controle , Infecções por Rotavirus/prevenção & controle , Vitamina A/uso terapêutico , Vitaminas/uso terapêutico , Fatores Etários , Diarreia/epidemiologia , Diarreia/virologia , Surtos de Doenças/prevenção & controle , Feminino , Guiné-Bissau/epidemiologia , Humanos , Incidência , Lactente , Recém-Nascido , Masculino , Infecções por Rotavirus/epidemiologia , Fatores Sexuais , Vitamina A/administração & dosagem , Vitaminas/administração & dosagemRESUMO
BACKGROUND: Monitoring of intracranial pressure (ICP) is important in the optimal treatment of various neurological and neurosurgical diseases. Telemetric ICP monitoring allows long-term measurements in the patient's everyday life and the possibility to perform additional measurements without the procedure related risks of repeated transducer insertions. MATERIALS AND METHODS: We identified all patients in our clinic with an implanted Raumedic(®) telemetric ICP probe (NEUROVENT(®)-P-tel). For each patient we identified diagnosis, indication for implantation, surgical complications, duration of ICP reading, number of ICP recording sessions (in relation to symptoms of increased ICP) and their clinical consequence. RESULTS: We included 21 patients in the evaluation (11 female and 10 male). Median age was 28 (2-83) years and median duration of disease was 11 (0-30) years. Eleven patients had various kinds of hydrocephalus, seven patients had idiopathic intracranial hypertension (IIH) and three patients had normal pressure hydrocephalus (NPH). Fifteen patients had a shunt prior to implantation. Median duration of implantation was 248 (49-666) days and median duration from implantation to last recording session was 154 (8-433) days. In total, 86 recording sessions were performed; 29 resulted in surgical shunt revision, 30 in change of acetazolamide dose or programmable valve setting, 20 required no action and 5 resulted in a new recording session. No surgical complications occurred, except for late wound infection at the surgical site in two patients. CONCLUSION: Telemetric ICP monitoring is useful in patients with complicated CSF dynamic disturbances who would otherwise require repeated invasive pressure monitoring. It seems to be a feasible method to guide adjustment of programmable valve settings and to identify patients with chronic or repeated shunt problems.
Assuntos
Monitorização Ambulatorial da Pressão Arterial/normas , Hidrocefalia/diagnóstico , Hipertensão Intracraniana/diagnóstico , Pressão Intracraniana/fisiologia , Próteses e Implantes , Infecção da Ferida Cirúrgica , Telemetria/normas , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Monitorização Ambulatorial da Pressão Arterial/métodos , Criança , Pré-Escolar , Dinamarca , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Próteses e Implantes/efeitos adversos , Telemetria/métodos , Adulto JovemRESUMO
BACKGROUND: WHO recommends high-dose Vitamin A supplementation (VAS) at vaccination contacts after 6 months of age. It has not been studied whether the effect of VAS on mortality depends on the type of vaccine. We have hypothesized that VAS administered with measles vaccine (MV) is more beneficial than VAS with diphtheria-tetanus-pertussis (DTP) vaccine. We assessed the effect of VAS administered with different vaccines during national immunization days (NIDs). METHODS: In 2003, VAS was distributed during NIDs in Guinea-Bissau. Children 6 months or older were given VAS, and if they were missing vaccines, these were often given as well. We compared survival between children who had received VAS alone, VAS with DTP or DTP + MV, or VAS with MV. We also compared the survival between participants and non-participants. We followed 6- to 17-month old children until 18 months of age and analysed survival in Cox models. RESULTS: Twenty of 982 VAS-recipients died during follow-up. The mortality rate ratio (MRR) for VAS with DTP + MV or VAS with DTP was 3.43 (1.36-8.61) compared with VAS only. There were no deaths among those who received VAS with MV alone (P = 0.0005 for homogeneity of VAS effects). Children who received VAS with DTP had higher mortality than non-participants who did not receive VAS [MRR = 3.04 (1.31-7.07)]. CONCLUSION: The study design does not allow for definite conclusions. However, the results are compatible with our a priori hypothesis that VAS is more beneficial when given with MV and potentially harmful when given with DTP. Randomized trials testing the impact on mortality of the current WHO policy seem warranted.
Assuntos
Suplementos Nutricionais , Vacina contra Difteria, Tétano e Coqueluche/administração & dosagem , Vacina contra Sarampo/administração & dosagem , Vitamina A/administração & dosagem , Vitaminas/administração & dosagem , Países em Desenvolvimento , Suplementos Nutricionais/efeitos adversos , Vacina contra Difteria, Tétano e Coqueluche/efeitos adversos , Esquema de Medicação , Interações Medicamentosas , Métodos Epidemiológicos , Feminino , Guiné-Bissau/epidemiologia , Humanos , Imunização , Lactente , Masculino , Vacina contra Sarampo/efeitos adversos , Vitamina A/efeitos adversosRESUMO
Many large intervention trials have shown that high-dose vitamin A supplementation decreases overall childhood mortality rates by 23-30%, making it one of the most cost-effective interventions in low-income countries. However, with regard to morbidity and the immunological mechanisms behind the beneficial effect on mortality rates, the results are less clear. Furthermore, vitamin A seems to be beneficial in some but not all age groups, and smaller doses may be even better than higher doses. It seems likely that by pursuing these inconsistent observations, vitamin A supplementation programmes can be optimised.